Condition
Endometriosis, Pain
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 2 (3)
Trial Status
Completed2
Not Yet Recruiting1
Withdrawn1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06834997Phase 2Withdrawn
Dronabinol As an Adjunct for Reducing Pain (DARP)-Texas Children's Hospital
NCT06795243Not ApplicableRecruiting
Efficacy of Physical Therapy Treatment in Endometriosis and Its Relationship to Adherence Rates.
NCT06997809Not ApplicableNot Yet RecruitingPrimary
ENDometriosis: Evaluation of Detection and Need for ALGOlogic Care Before Surgery
NCT00973973Phase 2CompletedPrimary
Efficacy and Safety Study of Elagolix in Women With Endometriosis
NCT00619866Phase 2CompletedPrimary
An Efficacy and Safety Study of Elagolix (NBI-56418) in Women With Endometriosis
Showing all 5 trials